Follicular lymphoma grade IIIa, intrapelvic lymph nodes
ICD-10 C82.36 is a billable code used to indicate a diagnosis of follicular lymphoma grade iiia, intrapelvic lymph nodes.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade IIIa indicates a higher grade of malignancy, where there is a predominance of large cells, and it is classified as a more aggressive form of the disease. In this case, the lymphoma is localized to the intrapelvic lymph nodes, which can include nodes in the iliac, inguinal, and pelvic regions. Patients may present with B-symptoms such as fever, night sweats, and weight loss, which are indicative of systemic involvement. Diagnosis typically involves imaging studies, such as CT scans, and biopsy of affected lymph nodes. Treatment protocols often include chemotherapy regimens, such as R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone), and may also involve radiation therapy depending on the extent of the disease and patient factors. The prognosis varies based on the stage at diagnosis and response to treatment.
Comprehensive documentation of diagnosis, staging, treatment plans, and follow-up care.
Patients presenting with lymphadenopathy, B-symptoms, or those undergoing chemotherapy.
Ensure accurate grading and staging are documented to support coding.
Detailed imaging reports that specify lymph node involvement and any changes over time.
Imaging studies performed for staging or monitoring treatment response.
Clear documentation of the location and size of lymph nodes is crucial for accurate coding.
Used during treatment of follicular lymphoma grade IIIa.
Document the specific chemotherapy regimen and patient response.
Oncology specialists should ensure accurate coding of chemotherapy administration.
Common treatment options include chemotherapy regimens such as R-CHOP, targeted therapies like Rituximab, and radiation therapy, depending on the stage and patient factors.
